Logo image of QUOT

Quotient Technology Inc (QUOT) Stock Fundamental Analysis

NYSE:QUOT - New York Stock Exchange, Inc. - US7491191034 - Common Stock - Currency: USD

3.99  0 (0%)

After market: 3.99 0 (0%)

Fundamental Rating

2

Overall QUOT gets a fundamental rating of 2 out of 10. We evaluated QUOT against 93 industry peers in the Media industry. Both the profitability and financial health of QUOT have multiple concerns. QUOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QUOT had negative earnings in the past year.
In the past year QUOT had a positive cash flow from operations.
In the past 5 years QUOT always reported negative net income.
QUOT had a positive operating cash flow in 4 of the past 5 years.
QUOT Yearly Net Income VS EBIT VS OCF VS FCFQUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M -60M

1.2 Ratios

The profitability ratios for QUOT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QUOT Yearly ROA, ROE, ROICQUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

QUOT has a Gross Margin of 49.75%. This is in the better half of the industry: QUOT outperforms 64.95% of its industry peers.
In the last couple of years the Gross Margin of QUOT has declined.
QUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
QUOT Yearly Profit, Operating, Gross MarginsQUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

QUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QUOT has more shares outstanding
The debt/assets ratio for QUOT has been reduced compared to a year ago.
QUOT Yearly Shares OutstandingQUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
QUOT Yearly Total Debt VS Total AssetsQUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.44, we must say that QUOT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.44, QUOT is doing worse than 78.35% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that QUOT is not too dependend on debt financing.
QUOT has a Debt to Equity ratio of 0.30. This is in the better half of the industry: QUOT outperforms 69.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACCN/A
WACC8.13%
QUOT Yearly LT Debt VS Equity VS FCFQUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.37 indicates that QUOT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.37, QUOT is not doing good in the industry: 60.82% of the companies in the same industry are doing better.
QUOT has a Quick Ratio of 1.37. This is a normal value and indicates that QUOT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of QUOT (1.37) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
QUOT Yearly Current Assets VS Current LiabilitesQUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.44% over the past year.
QUOT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.13%.
Measured over the past years, QUOT shows a decrease in Revenue. The Revenue has been decreasing by -2.16% on average per year.
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%

3.2 Future

QUOT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.32% yearly.
The Revenue is expected to grow by 2.18% on average over the next years.
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QUOT Yearly Revenue VS EstimatesQUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
QUOT Yearly EPS VS EstimatesQUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

QUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 130.39, the valuation of QUOT can be described as expensive.
69.07% of the companies in the same industry are cheaper than QUOT, based on the Price/Forward Earnings ratio.
QUOT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE N/A
Fwd PE 130.39
QUOT Price Earnings VS Forward Price EarningsQUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QUOT Per share dataQUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
QUOT's earnings are expected to grow with 29.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.74%
EPS Next 3Y29.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Quotient Technology Inc

NYSE:QUOT (9/1/2023, 8:04:00 PM)

After market: 3.99 0 (0%)

3.99

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-08 2023-08-08/amc
Earnings (Next)11-06 2023-11-06/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners7.64%
Ins Owner Change0%
Market Cap397.92M
Analysts45.71
Price Target4.08 (2.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.79%
Min EPS beat(2)-171.49%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-179.71%
Min EPS beat(4)-271.57%
Max EPS beat(4)-96.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.04%
Min Revenue beat(2)-6.87%
Max Revenue beat(2)-3.21%
Revenue beat(4)0
Avg Revenue beat(4)-8.73%
Min Revenue beat(4)-17.12%
Max Revenue beat(4)-3.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-344.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 130.39
P/S 1.5
P/FCF N/A
P/OCF 73.77
P/B 2.56
P/tB 16.14
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)0.03
Fwd EY0.77%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.05
OCFY1.36%
SpS2.67
BVpS1.56
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.69%
Cap/Sales 7.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z -0.44
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)63.54%
Cap/Depr(5y)74.54%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A
EBIT growth 1Y30.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.87%
EBIT Next 3Y58.55%
EBIT Next 5YN/A
FCF growth 1Y-168.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85%
OCF growth 3YN/A
OCF growth 5YN/A